Difference between revisions of "Template:Glutamate receptor modulators"

From blackwiki
Jump to navigation Jump to search
imported>Meodipt
imported>Ronhjones
m (subst:'ing, replaced: {{•}} →  • (236) using AWB)
Line 10: Line 10:
  
 
     | group1 = [[AMPA receptor|AMPA]]
 
     | group1 = [[AMPA receptor|AMPA]]
     | list1  = '''[[Ampakine|Agonists]]:''' [[5-Fluorowillardiine]]{{•}} [[AMPA]]{{•}} [[Domoic acid]]{{•}} [[Quisqualic acid]]; ''[[Positive allosteric modulator]]s:'' [[Aniracetam]]{{•}} [[Cyclothiazide]]{{•}} [[CX-516]]{{•}} [[CX-546]]{{•}} [[CX-614]]{{•}} [[CX-691]]{{•}} [[CX-717]]{{•}} [[Diazoxide]]{{•}} [[Hydrochlorothiazide|HCTZ]]{{•}} [[IDRA-21]]{{•}} [[LY-392,098]]{{•}} [[LY-404,187]]{{•}} [[LY-451,395]]{{•}} [[LY-451,646]]{{•}} [[LY-503,430]]{{•}} [[Oxiracetam]]{{•}} [[PEPA (drug)|PEPA]]{{•}} [[Piracetam]]{{•}} [[Pramiracetam]]{{•}} [[S-18986]]{{•}} [[Sunifiram]]{{•}} [[Unifiram]]<br/>'''Antagonists:''' [[ATPO]]{{•}} [[Barbiturates]]{{•}} [[Caroverine]]{{•}} [[CNQX]]{{•}} [[DNQX]]{{•}} [[GYKI-52466]]{{•}} [[NBQX]]{{•}} [[Perampanel]]{{•}} [[Talampanel]]{{•}} [[Tezampanel]]{{•}} [[Topiramate]]; ''[[Negative allosteric modulator]]s:'' [[GYKI-53,655]]
+
     | list1  = '''[[Ampakine|Agonists]]:''' [[5-Fluorowillardiine]]&#160;&#8226;  [[AMPA]]&#160;&#8226;  [[Domoic acid]]&#160;&#8226;  [[Quisqualic acid]]; ''[[Positive allosteric modulator]]s:'' [[Aniracetam]]&#160;&#8226;  [[Cyclothiazide]]&#160;&#8226;  [[CX-516]]&#160;&#8226;  [[CX-546]]&#160;&#8226;  [[CX-614]]&#160;&#8226;  [[CX-691]]&#160;&#8226;  [[CX-717]]&#160;&#8226;  [[Diazoxide]]&#160;&#8226;  [[Hydrochlorothiazide|HCTZ]]&#160;&#8226;  [[IDRA-21]]&#160;&#8226;  [[LY-392,098]]&#160;&#8226;  [[LY-404,187]]&#160;&#8226;  [[LY-451,395]]&#160;&#8226;  [[LY-451,646]]&#160;&#8226;  [[LY-503,430]]&#160;&#8226;  [[Oxiracetam]]&#160;&#8226;  [[PEPA (drug)|PEPA]]&#160;&#8226;  [[Piracetam]]&#160;&#8226;  [[Pramiracetam]]&#160;&#8226;  [[S-18986]]&#160;&#8226;  [[Sunifiram]]&#160;&#8226;  [[Unifiram]]<br/>'''Antagonists:''' [[ATPO]]&#160;&#8226;  [[Barbiturates]]&#160;&#8226;  [[Caroverine]]&#160;&#8226;  [[CNQX]]&#160;&#8226;  [[DNQX]]&#160;&#8226;  [[GYKI-52466]]&#160;&#8226;  [[NBQX]]&#160;&#8226;  [[Perampanel]]&#160;&#8226;  [[Talampanel]]&#160;&#8226;  [[Tezampanel]]&#160;&#8226;  [[Topiramate]]; ''[[Negative allosteric modulator]]s:'' [[GYKI-53,655]]
  
 
     | group2 = [[NMDA receptor|NMDA]]
 
     | group2 = [[NMDA receptor|NMDA]]
     | list2  = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]{{•}} [[Glutamate]]{{•}} [[Homoquinolinic acid]]{{•}} [[Ibotenic acid]]{{•}} [[NMDA]]{{•}} [[Quinolinic acid]]{{•}} [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]]{{•}} [[ACPC]]{{•}} [[ACPD]]{{•}} [[Alanine]]{{•}} [[Carboxycyclopropylglycine|CCG]]{{•}} [[Cycloserine]]{{•}} [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]]{{•}} [[Fluoroalanine]]{{•}} [[Glycine]]{{•}} [[HA-966]]{{•}} [[L-687,414]]{{•}} [[Milacemide]]{{•}} [[Sarcosine]]{{•}} [[Serine]]{{•}} [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]]{{•}} [[Spermidine]]{{•}} [[Spermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]{{•}} [[AP-7 (drug)|AP7]]{{•}} [[CGP-37849]]{{•}} [[CGP-39551]]{{•}} [[CGP-39653]]{{•}} [[CGP-40116]]{{•}} [[CGS-19755]]{{•}} [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]]{{•}} [[LY-233,053]]{{•}} [[LY-235,959]]{{•}} [[LY-274,614]]{{•}} [[MDL-100,453]]{{•}} [[Midafotel|Midafotel (d-CPPene)]]{{•}} [[NPC-12,626]]{{•}} [[NPC-17,742]]{{•}} [[PBPD]]{{•}} [[PEAQX]]{{•}} [[Perzinfotel]]{{•}} [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]{{•}} [[SDZ-220581]]{{•}} [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]]{{•}} [[Caroverine]]{{•}} [[Dexanabinol]]{{•}} [[FPL-12495]]{{•}} [[FR-115,427]]{{•}} [[Hodgkinsine]]{{•}} [[Magnesium]]{{•}} [[MDL-27,266]]{{•}} [[NPS-1506]]{{•}} [[Psychotridine]]{{•}} [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]{{•}} [[3-MeO-PCP]]{{•}} [[8a-Phenyldecahydroquinoline|8A-PDHQ]]{{•}} [[Amantadine]]{{•}} [[Aptiganel]]{{•}} [[ARL-12,495]]{{•}} [[ARL-15,896-AR]]{{•}} [[ARL-16,247]]{{•}} [[Budipine]]{{•}} [[Delucemine]]{{•}} [[Dexoxadrol]]{{•}} [[Dextrallorphan]]{{•}} [[Dieticyclidine]]{{•}} [[Dizocilpine]]{{•}} [[Endopsychosin]]{{•}} [[Esketamine]]{{•}} [[Etoxadrol]]{{•}} [[Eticyclidine]]{{•}} [[Gacyclidine]]{{•}} [[Ibogaine]]{{•}} [[Indantadol]]{{•}} [[Ketamine]]{{•}} [[Ketobemidone]]{{•}} [[Loperamide]]{{•}} [[Memantine]]{{•}} [[Meperidine|Meperidine (Pethidine)]]{{•}} [[Methadone]]{{•}} [[Methorphan]] ([[Dextromethorphan]], [[Levomethorphan]]){{•}} [[Methoxetamine]]{{•}} [[Milnacipran]]{{•}} [[Morphanol]] ([[Dextrorphan]], [[Levorphanol]]){{•}} [[NEFA (drug)|NEFA]]{{•}} [[Neramexane]]{{•}} [[Nitrous oxide]]{{•}} [[Noribogaine]]{{•}} [[Orphenadrine]]{{•}} [[PCPr]]{{•}} [[Phencyclamine]]{{•}} [[Phencyclidine]]{{•}} [[Propoxyphene]]{{•}} [[Remacemide]]{{•}} [[Rhynchophylline]]{{•}} [[Riluzole]]{{•}} [[Rimantadine]]{{•}} [[Rolicyclidine]]{{•}} [[Sabeluzole]]{{•}} [[Tenocyclidine]]{{•}} [[Tiletamine]]{{•}} [[Tramadol]]{{•}} [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]]{{•}} [[ACEA-1328]]{{•}} [[1-Aminocyclopropanecarboxylic acid|ACPC]]{{•}} [[Carisoprodol]]{{•}} [[CGP-39653]]{{•}} [[7-Chlorokynurenate|CKA]]{{•}} [[DCKA]]{{•}} [[Felbamate]]{{•}} [[Gavestinel]]{{•}} [[GV-196,771]]{{•}} [[Kynurenic acid]]{{•}} [[L-689,560]]{{•}} [[L-701,324]]{{•}} [[Lacosamide]]{{•}} [[Licostinel]]{{•}} [[LU-73,068]]{{•}} [[MDL-105,519]]{{•}} [[Meprobamate]]{{•}} [[MRZ 2/576]]{{•}} [[PNQX]]{{•}} [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]]{{•}} [[CO-101,244|CO-101,244 (PD-174,494)]]{{•}} [[CP-101,606]]{{•}} [[Eliprodil]]{{•}} [[Haloperidol]]{{•}} [[Ifenprodil]]{{•}} [[Isoxsuprine]]{{•}} [[Nylidrin]]{{•}} [[Ro8-4304]]{{•}} [[Ro25-6981]]{{•}} [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]{{•}} [[Co 101676]]{{•}} [[1,3-Diaminopropane|Diaminopropane]]{{•}} [[Diethylenetriamine]]{{•}} [[Huperzine A]]{{•}} [[Putrescine]]{{•}} [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]]{{•}} [[Diethyl ether]]{{•}} [[Enflurane]]{{•}} [[Ethanol|Ethanol (Alcohol)]]{{•}} [[Halothane]]{{•}} [[Isoflurane]]{{•}} [[Methoxyflurane]]{{•}} [[Toluene]]{{•}} [[1,1,1-Trichloroethane|Trichloroethane]]{{•}} [[2,2,2-Trichloroethanol|Trichloroethanol]]{{•}} [[Trichloroethylene]]{{•}} [[Xylene]]
+
     | list2  = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]&#160;&#8226;  [[Glutamate]]&#160;&#8226;  [[Homoquinolinic acid]]&#160;&#8226;  [[Ibotenic acid]]&#160;&#8226;  [[NMDA]]&#160;&#8226;  [[Quinolinic acid]]&#160;&#8226;  [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]]&#160;&#8226;  [[ACPC]]&#160;&#8226;  [[ACPD]]&#160;&#8226;  [[Alanine]]&#160;&#8226;  [[Carboxycyclopropylglycine|CCG]]&#160;&#8226;  [[Cycloserine]]&#160;&#8226;  [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]]&#160;&#8226;  [[Fluoroalanine]]&#160;&#8226;  [[Glycine]]&#160;&#8226;  [[HA-966]]&#160;&#8226;  [[L-687,414]]&#160;&#8226;  [[Milacemide]]&#160;&#8226;  [[Sarcosine]]&#160;&#8226;  [[Serine]]&#160;&#8226;  [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]]&#160;&#8226;  [[Spermidine]]&#160;&#8226;  [[Spermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]&#160;&#8226;  [[AP-7 (drug)|AP7]]&#160;&#8226;  [[CGP-37849]]&#160;&#8226;  [[CGP-39551]]&#160;&#8226;  [[CGP-39653]]&#160;&#8226;  [[CGP-40116]]&#160;&#8226;  [[CGS-19755]]&#160;&#8226;  [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]]&#160;&#8226;  [[LY-233,053]]&#160;&#8226;  [[LY-235,959]]&#160;&#8226;  [[LY-274,614]]&#160;&#8226;  [[MDL-100,453]]&#160;&#8226;  [[Midafotel|Midafotel (d-CPPene)]]&#160;&#8226;  [[NPC-12,626]]&#160;&#8226;  [[NPC-17,742]]&#160;&#8226;  [[PBPD]]&#160;&#8226;  [[PEAQX]]&#160;&#8226;  [[Perzinfotel]]&#160;&#8226;  [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]&#160;&#8226;  [[SDZ-220581]]&#160;&#8226;  [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]]&#160;&#8226;  [[Caroverine]]&#160;&#8226;  [[Dexanabinol]]&#160;&#8226;  [[FPL-12495]]&#160;&#8226;  [[FR-115,427]]&#160;&#8226;  [[Hodgkinsine]]&#160;&#8226;  [[Magnesium]]&#160;&#8226;  [[MDL-27,266]]&#160;&#8226;  [[NPS-1506]]&#160;&#8226;  [[Psychotridine]]&#160;&#8226;  [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]&#160;&#8226;  [[3-MeO-PCP]]&#160;&#8226;  [[8a-Phenyldecahydroquinoline|8A-PDHQ]]&#160;&#8226;  [[Amantadine]]&#160;&#8226;  [[Aptiganel]]&#160;&#8226;  [[ARL-12,495]]&#160;&#8226;  [[ARL-15,896-AR]]&#160;&#8226;  [[ARL-16,247]]&#160;&#8226;  [[Budipine]]&#160;&#8226;  [[Delucemine]]&#160;&#8226;  [[Dexoxadrol]]&#160;&#8226;  [[Dextrallorphan]]&#160;&#8226;  [[Dieticyclidine]]&#160;&#8226;  [[Dizocilpine]]&#160;&#8226;  [[Endopsychosin]]&#160;&#8226;  [[Esketamine]]&#160;&#8226;  [[Etoxadrol]]&#160;&#8226;  [[Eticyclidine]]&#160;&#8226;  [[Gacyclidine]]&#160;&#8226;  [[Ibogaine]]&#160;&#8226;  [[Indantadol]]&#160;&#8226;  [[Ketamine]]&#160;&#8226;  [[Ketobemidone]]&#160;&#8226;  [[Loperamide]]&#160;&#8226;  [[Memantine]]&#160;&#8226;  [[Meperidine|Meperidine (Pethidine)]]&#160;&#8226;  [[Methadone]]&#160;&#8226;  [[Methorphan]] ([[Dextromethorphan]], [[Levomethorphan]])&#160;&#8226;  [[Methoxetamine]]&#160;&#8226;  [[Milnacipran]]&#160;&#8226;  [[Morphanol]] ([[Dextrorphan]], [[Levorphanol]])&#160;&#8226;  [[NEFA (drug)|NEFA]]&#160;&#8226;  [[Neramexane]]&#160;&#8226;  [[Nitrous oxide]]&#160;&#8226;  [[Noribogaine]]&#160;&#8226;  [[Orphenadrine]]&#160;&#8226;  [[PCPr]]&#160;&#8226;  [[Phencyclamine]]&#160;&#8226;  [[Phencyclidine]]&#160;&#8226;  [[Propoxyphene]]&#160;&#8226;  [[Remacemide]]&#160;&#8226;  [[Rhynchophylline]]&#160;&#8226;  [[Riluzole]]&#160;&#8226;  [[Rimantadine]]&#160;&#8226;  [[Rolicyclidine]]&#160;&#8226;  [[Sabeluzole]]&#160;&#8226;  [[Tenocyclidine]]&#160;&#8226;  [[Tiletamine]]&#160;&#8226;  [[Tramadol]]&#160;&#8226;  [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]]&#160;&#8226;  [[ACEA-1328]]&#160;&#8226;  [[1-Aminocyclopropanecarboxylic acid|ACPC]]&#160;&#8226;  [[Carisoprodol]]&#160;&#8226;  [[CGP-39653]]&#160;&#8226;  [[7-Chlorokynurenate|CKA]]&#160;&#8226;  [[DCKA]]&#160;&#8226;  [[Felbamate]]&#160;&#8226;  [[Gavestinel]]&#160;&#8226;  [[GV-196,771]]&#160;&#8226;  [[Kynurenic acid]]&#160;&#8226;  [[L-689,560]]&#160;&#8226;  [[L-701,324]]&#160;&#8226;  [[Lacosamide]]&#160;&#8226;  [[Licostinel]]&#160;&#8226;  [[LU-73,068]]&#160;&#8226;  [[MDL-105,519]]&#160;&#8226;  [[Meprobamate]]&#160;&#8226;  [[MRZ 2/576]]&#160;&#8226;  [[PNQX]]&#160;&#8226;  [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]]&#160;&#8226;  [[CO-101,244|CO-101,244 (PD-174,494)]]&#160;&#8226;  [[CP-101,606]]&#160;&#8226;  [[Eliprodil]]&#160;&#8226;  [[Haloperidol]]&#160;&#8226;  [[Ifenprodil]]&#160;&#8226;  [[Isoxsuprine]]&#160;&#8226;  [[Nylidrin]]&#160;&#8226;  [[Ro8-4304]]&#160;&#8226;  [[Ro25-6981]]&#160;&#8226;  [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]&#160;&#8226;  [[Co 101676]]&#160;&#8226;  [[1,3-Diaminopropane|Diaminopropane]]&#160;&#8226;  [[Diethylenetriamine]]&#160;&#8226;  [[Huperzine A]]&#160;&#8226;  [[Putrescine]]&#160;&#8226;  [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]]&#160;&#8226;  [[Diethyl ether]]&#160;&#8226;  [[Enflurane]]&#160;&#8226;  [[Ethanol|Ethanol (Alcohol)]]&#160;&#8226;  [[Halothane]]&#160;&#8226;  [[Isoflurane]]&#160;&#8226;  [[Methoxyflurane]]&#160;&#8226;  [[Toluene]]&#160;&#8226;  [[1,1,1-Trichloroethane|Trichloroethane]]&#160;&#8226;  [[2,2,2-Trichloroethanol|Trichloroethanol]]&#160;&#8226;  [[Trichloroethylene]]&#160;&#8226;  [[Xylene]]
  
 
     | group3 = [[Kainate receptor|Kainate]]
 
     | group3 = [[Kainate receptor|Kainate]]
     | list3  = '''Agonists:''' [[5-Iodowillardiine]]{{•}} [[ATPA]]{{•}} [[Domoic acid]]{{•}} [[Kainic acid]]{{•}} [[LY-339,434]]{{•}} [[SYM-2081]]<br/>'''Antagonists:''' [[CNQX]]{{•}} [[DNQX]]{{•}} [[LY-382,884]]{{•}} [[NBQX]]{{•}} [[NS102]]{{•}} [[Tezampanel]]{{•}} [[Topiramate]]{{•}} [[UBP-302]]; ''Negative allosteric modulators:'' [[NS-3763]]
+
     | list3  = '''Agonists:''' [[5-Iodowillardiine]]&#160;&#8226;  [[ATPA]]&#160;&#8226;  [[Domoic acid]]&#160;&#8226;  [[Kainic acid]]&#160;&#8226;  [[LY-339,434]]&#160;&#8226;  [[SYM-2081]]<br/>'''Antagonists:''' [[CNQX]]&#160;&#8226;  [[DNQX]]&#160;&#8226;  [[LY-382,884]]&#160;&#8226;  [[NBQX]]&#160;&#8226;  [[NS102]]&#160;&#8226;  [[Tezampanel]]&#160;&#8226;  [[Topiramate]]&#160;&#8226;  [[UBP-302]]; ''Negative allosteric modulators:'' [[NS-3763]]
  
 
     }}
 
     }}
Line 25: Line 25:
  
 
     | group1 = [[Metabotropic_glutamate_receptor#Group_I|Group I]]
 
     | group1 = [[Metabotropic_glutamate_receptor#Group_I|Group I]]
     | list1  = '''Agonists:''' ''Unselective:'' [[ACPD]]{{•}} [[Dihydroxyphenylglycine|DHPG]]{{•}} [[Quisqualic acid]]; ''mGlu1-selective:'' [[Ro01-6128]]{{•}} [[Ro67-4853]]{{•}} [[Ro67-7476]]{{•}} [[VU-71]]; ''mGlu5-selective:'' [[ADX-47273]]{{•}} [[CDPPB]]{{•}} [[CHPG]]{{•}} [[1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine|DFB]]{{•}} [[VU-1545]]<br/>'''Antagonists:''' ''Unselective:'' [[MCPG]]{{•}} [[NPS-2390]]; ''mGlu1-selective:'' [[BAY 36-7620]]{{•}} [[CPCCOEt]]{{•}} [[LY-367,385]]{{•}} [[LY-456,236]]; ''mGlu5-selective:'' [[DMeOB]]{{•}} [[Fenobam]]{{•}} [[LY-344,545]]{{•}} [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]]{{•}} [[MTEP]]{{•}} [[SIB-1757]]{{•}} [[SIB-1893]]  
+
     | list1  = '''Agonists:''' ''Unselective:'' [[ACPD]]&#160;&#8226;  [[Dihydroxyphenylglycine|DHPG]]&#160;&#8226;  [[Quisqualic acid]]; ''mGlu1-selective:'' [[Ro01-6128]]&#160;&#8226;  [[Ro67-4853]]&#160;&#8226;  [[Ro67-7476]]&#160;&#8226;  [[VU-71]]; ''mGlu5-selective:'' [[ADX-47273]]&#160;&#8226;  [[CDPPB]]&#160;&#8226;  [[CHPG]]&#160;&#8226;  [[1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine|DFB]]&#160;&#8226;  [[VU-1545]]<br/>'''Antagonists:''' ''Unselective:'' [[MCPG]]&#160;&#8226;  [[NPS-2390]]; ''mGlu1-selective:'' [[BAY 36-7620]]&#160;&#8226;  [[CPCCOEt]]&#160;&#8226;  [[LY-367,385]]&#160;&#8226;  [[LY-456,236]]; ''mGlu5-selective:'' [[DMeOB]]&#160;&#8226;  [[Fenobam]]&#160;&#8226;  [[LY-344,545]]&#160;&#8226;  [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]]&#160;&#8226;  [[MTEP]]&#160;&#8226;  [[SIB-1757]]&#160;&#8226;  [[SIB-1893]]  
  
 
     | group2 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group II]]
 
     | group2 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group II]]
     | list2  = '''Agonists:''' ''Unselective:'' [[CBiPES]]{{•}} [[DCG-IV]]{{•}} [[Eglumegad]]{{•}} [[LY-379,268]]{{•}} [[LY-404,039]]{{•}} [[LY-487,379]]{{•}} [[MGS-0028]]; ''mGlu2-selective:'' [[Biphenylindanone A|BINA]]{{•}} [[LY-566,332]]<br/>'''Antagonists:''' ''Unselective:'' [[APICA (drug)|APICA]]{{•}} [[EGLU]]{{•}} [[HYDIA]]{{•}} [[LY-307,452]]{{•}} [[LY-341,495]]{{•}} [[MCPG]]{{•}} [[MGS-0039]]: ''mGlu2-selective:'' [[PCCG-4]]; ''mGlu3-selective:'' [[CECXG]]
+
     | list2  = '''Agonists:''' ''Unselective:'' [[CBiPES]]&#160;&#8226;  [[DCG-IV]]&#160;&#8226;  [[Eglumegad]]&#160;&#8226;  [[LY-379,268]]&#160;&#8226;  [[LY-404,039]]&#160;&#8226;  [[LY-487,379]]&#160;&#8226;  [[MGS-0028]]; ''mGlu2-selective:'' [[Biphenylindanone A|BINA]]&#160;&#8226;  [[LY-566,332]]<br/>'''Antagonists:''' ''Unselective:'' [[APICA (drug)|APICA]]&#160;&#8226;  [[EGLU]]&#160;&#8226;  [[HYDIA]]&#160;&#8226;  [[LY-307,452]]&#160;&#8226;  [[LY-341,495]]&#160;&#8226;  [[MCPG]]&#160;&#8226;  [[MGS-0039]]: ''mGlu2-selective:'' [[PCCG-4]]; ''mGlu3-selective:'' [[CECXG]]
  
 
     | group3 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group III]]
 
     | group3 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group III]]
     | list3  = '''Agonists:''' ''Unselective:'' [[L-AP4]]; ''mGlu4-selective:'' [[PHCCC]]{{•}} [[VU-001,171]]{{•}} [[VU-0155,041]]; ''mGlu7-selective:'' [[AMN082]]; ''mGlu8-selective:'' [[DCPG]]<br/>'''Antagonists:''' ''Unselective:'' [[CPPG]]{{•}} [[MAP4 (drug)|MAP4]]{{•}} [[MSOP (drug)|MSOP]]{{•}} [[MPPG]]{{•}} [[MTPG]]{{•}} [[UBP-1112]]; ''mGlu7-selective:'' [[MMPIP]]
+
     | list3  = '''Agonists:''' ''Unselective:'' [[L-AP4]]; ''mGlu4-selective:'' [[PHCCC]]&#160;&#8226;  [[VU-001,171]]&#160;&#8226;  [[VU-0155,041]]; ''mGlu7-selective:'' [[AMN082]]; ''mGlu8-selective:'' [[DCPG]]<br/>'''Antagonists:''' ''Unselective:'' [[CPPG]]&#160;&#8226;  [[MAP4 (drug)|MAP4]]&#160;&#8226;  [[MSOP (drug)|MSOP]]&#160;&#8226;  [[MPPG]]&#160;&#8226;  [[MTPG]]&#160;&#8226;  [[UBP-1112]]; ''mGlu7-selective:'' [[MMPIP]]
  
 
     }}
 
     }}
Line 40: Line 40:
  
 
     | group1 = [[Glutamate transporter|EAAT]]s
 
     | group1 = [[Glutamate transporter|EAAT]]s
     |  list1 = [[Dihydrokainic acid|DHKA]]{{•}} [[L-trans-Pyrrolidine-2,4-dicarboxylic acid|PDC]]{{•}} [[WAY-213,613]]
+
     |  list1 = [[Dihydrokainic acid|DHKA]]&#160;&#8226;  [[L-trans-Pyrrolidine-2,4-dicarboxylic acid|PDC]]&#160;&#8226;  [[WAY-213,613]]
  
 
     | group2 = [[Vesicular glutamate transporters|vGluTs]]
 
     | group2 = [[Vesicular glutamate transporters|vGluTs]]
     |  list2 = [[7-Chlorokynurenic acid|7-CKA]]{{•}} [[Evans blue]]
+
     |  list2 = [[7-Chlorokynurenic acid|7-CKA]]&#160;&#8226;  [[Evans blue]]
  
 
   }}
 
   }}

Revision as of 22:58, 30 December 2010